Your browser doesn't support javascript.
loading
p-Tau immunotherapy reduces soluble and insoluble tau in aged 3xTg-AD mice.
Walls, Ken C; Ager, Rahasson R; Vasilevko, Vitaly; Cheng, Dave; Medeiros, Rodrigo; LaFerla, Frank M.
Afiliação
  • Walls KC; Department of Neurobiology and Behavior, University of California, Irvine, CA, United States.
  • Ager RR; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, United States.
  • Vasilevko V; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, United States.
  • Cheng D; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, United States.
  • Medeiros R; Department of Neurobiology and Behavior, University of California, Irvine, CA, United States; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, United States.
  • LaFerla FM; Department of Neurobiology and Behavior, University of California, Irvine, CA, United States; Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, CA, United States. Electronic address: laferla@uci.edu.
Neurosci Lett ; 575: 96-100, 2014 Jul 11.
Article em En | MEDLINE | ID: mdl-24887583

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas tau / Doença de Alzheimer / Anticorpos Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas tau / Doença de Alzheimer / Anticorpos Limite: Animals Idioma: En Ano de publicação: 2014 Tipo de documento: Article